Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.7304
+0.0009 (0.12%)
Jun 16, 2026, 3:16 PM EDT - Market open
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $25.66 million as of June 16, 2026. Its market cap has decreased by -63.03% in one year.
Market Cap
25.66M
Enterprise Value
8.06M
1-Year Change
-63.03%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $25.66M, a decrease of -92.80%. That is a compound annual growth rate of -70.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 25.66M | 6.90% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evaxion | 30.36M |
| Daré Bioscience | 30.26M |
| ABVC BioPharma | 30.07M |
| Senti Biosciences Holdings | 29.90M |
| Kyntra Bio | 28.86M |
| NanoViricides | 27.79M |
| IGC Pharma | 27.66M |
| Serina Therapeutics | 27.41M |